Percutaneous coronary intervention with second-generation drug-eluting stent versus bare-metal stent: Systematic review and cost-benefit analysis.
Thomas G PoderJihane ErrajiLucien P CoulibalyKouamé KoffiPublished in: PloS one (2017)
Despite the higher purchase cost of DES-2s compared to BMSs, generalizing their use, in particular for patients at high risk of reintervention, should enable significant savings.
Keyphrases
- systematic review
- percutaneous coronary intervention
- meta analyses
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery bypass grafting
- atrial fibrillation
- randomized controlled trial
- heart failure
- left ventricular
- data analysis